~~<i id='9F84C1E861'><strike id='9F84C1E861'><tt id='9F84C1E861'><pre id='9F84C1E861'></pre></tt></strike></i>~~

Home» focus» hotspot

hotspot

author：leisure time 2025-09-28 06:00:48 Page View：91

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Ancient Greek ideas underpin modern concepts of pregnancy
Next article： At least 13 dead in Texas as scorching temps continue

comprehensive

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

Radiation, mainstay of cancer treatment, begins a fade

Amaskusedinradiationtherapyshowslaserlinesfortargetingcancercellsinthebrain.AdobeEveryyear,doctorsge

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

How a symptom of dementia informs our understanding of creativity

AnexampleofAnneAdams’artworkaftershewasdiagnosedwithFTD.VisualrepresentationofMauriceRavel’sBoléroCo

WSS

hotspot

hotspot

explore

comprehensive

How a symptom of dementia informs our understanding of creativity